4D Molecular Therapeutics raises ~$93.3M net in public offering of common stock and pre-funded warrants

4D Molecular Therapeutics, Inc.

Sold 8,385,809 shares at $10.51/share and 1,128,949 pre-funded warrants at $10.5099 each.
Net proceeds approximately $93.3M after underwriting discounts and estimated expenses.
Offering closed on November 7, 2025; insiders subject to lock-up until January 6, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.